Sweden · Biopharma startup
Sweden · Dilafor
Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications.
Funding reportedLast round: Undisclosed round
What company datasets say Dilafor raised
Funding, as reported
Reported in all51Min the source's currency
Rounds1
Last roundUndisclosed round
Last round dateSept 2016
Investors listed3
Biopharma in Sweden
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Dilafor in front of investors. Or tell us what we have wrong.